Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M406185200 on September 24, 2004

J. Biol. Chem., Vol. 279, Issue 50, 52338-52345, December 10, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/50/52338    most recent
M406185200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chien, C.-H.
Right arrow Articles by Chen, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chien, C.-H.
Right arrow Articles by Chen, X.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

One Site Mutation Disrupts Dimer Formation in Human DPP-IV Proteins*

Chia-Hui Chien{ddagger}§, Li-Hao Huang{ddagger}§, Chi-Yuan Chou¶, Yuan-Shou Chen{ddagger}, Yu-San Han{ddagger}, Gu-Gang Chang||, Po-Huang Liang**, and Xin Chen{ddagger}{ddagger}{ddagger}

From the {ddagger}Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei 115, the Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 115, the ||Faculty of Life Science, National Yang-Ming University, Taipei 112, and the **Institute of Biological Chemistry, Academia Sinica, Nankang, Taipei 115, Taiwan, Republic of China

DPP-IV is a prolyl dipeptidase, cleaving the peptide bond after the penultimate proline residue. It is an important drug target for the treatment of type II diabetes. DPP-IV is active as a dimer, and monomeric DPP-IV has been speculated to be inactive. In this study, we have identified the C-terminal loop of DPP-IV, highly conserved among prolyl dipeptidases, as essential for dimer formation and optimal catalysis. The conserved residue His750 on the loop contributes significantly for dimer stability. We have determined the quaternary structures of the wild type, H750A, and H750E mutant enzymes by several independent methods including chemical cross-linking, gel electrophoresis, size exclusion chromatography, and analytical ultracentrifugation. Wild-type DPP-IV exists as dimers both in the intact cell and in vitro after purification from human semen or insect cells. The H750A mutation results in a mixture of DPP-IV dimer and monomer. H750A dimer has the same kinetic constants as those of the wild type, whereas the H750A monomer has a 60-fold decrease in kcat. Replacement of His750 with a negatively charged Glu (H750E) results in nearly exclusive monomers with a 300-fold decrease in catalytic activity. Interestingly, there is no dynamic equilibrium between the dimer and the monomer for all forms of DPP-IVs studied here. This is the first study of the function of the C-terminal loop as well as monomeric mutant DPP-IVs with respect to their enzymatic activities. The study has important implications for the discovery of drugs targeted to the dimer interface.


Received for publication, June 3, 2004 , and in revised form, September 23, 2004.

* This work was supported by NHRI Grant BP-093-PP-03 from the National Health Research Institutes, Taipei, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

{ddagger}{ddagger} To whom correspondence should be addressed: Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Taipei, Taiwan, ROC. Tel.: 8862-26534401 (ext. 6113); Fax: 8862-27890264; E-mail: xchen{at}nhri.org.tw.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Ohnuma, M. Uchiyama, T. Yamochi, K. Nishibashi, O. Hosono, N. Takahashi, S. Kina, H. Tanaka, X. Lin, N. H. Dang, et al.
Caveolin-1 Triggers T-cell Activation via CD26 in Association with CARMA1
J. Biol. Chem., March 30, 2007; 282(13): 10117 - 10131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-J. Lee, Y.-S. Chen, C.-Y. Chou, C.-H. Chien, C.-H. Lin, G.-G. Chang, and X. Chen
Investigation of the Dimer Interface and Substrate Specificity of Prolyl Dipeptidase DPP8
J. Biol. Chem., December 15, 2006; 281(50): 38653 - 38662.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. N. Lee, K. W. Jackson, V. J. Christiansen, C. S. Lee, J.-G. Chun, and P. A. McKee
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
Blood, February 15, 2006; 107(4): 1397 - 1404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement